VentureDNA Logo imageVentureDNA Logo image

VentureDNA

Play It Forward

  • Who We Are
  • What We Do
  • What We Have Done
  • Our Team
  • Contact Us

HERA BIOTECH

Hera Biotech Is Developing and Commercializing The World’s 1st Non-Surgical Test For Definitive Diagnosis And Staging Of Endometriosis. Hera’s initial goal is to commercialize the MetriDx™, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. Endometriosis is defined as the presence of endometrial glands and stromal-like lesions outside of the uterus. Endometriosis affects 10-20% of all women of reproductive age; 7-13 million in the US alone. Current diagnosis of endometriosis is by visualization during laparoscopic surgery, confirmed by histological pathology, performed under general anesthesia by a surgeon or gynecologist. The VentureDNA team is providing advisory services to senior management, while opening access to its worldwide network of marketing and medical professionals. Please visit: Hera Biotech 
Share
Categories
Advisory Services

Previous Portfolio

SOLVD Health

Next Portfolio

BioMech

Related Projects/Works

biopods

BIOPODS

by joeson rosario
digital

REGO

by joeson rosario
augury-systems

AUGURY SYSTEMS

by joeson rosario
Presentation2 2

Click IPO

by joeson rosario
VentureDNA Logo imageVentureDNA Logo image

VentureDNA

Play It Forward

We partner with great management teams to take their businesses to the next level, creating value for all stakeholders.

Please see Weild & Co.’s Regulation Best Interest, Form CRS Disclosure Here.

Securities transactions effected through Weild & Co., member FINRA/SIPC.

SITEMAP

  • Who We Are
  • What We Do
  • What We Have Done
  • Our Team
  • Contact Us

LEGAL

  • Terms of Use
  • Privacy Policy

CONTACT

1022 North Western Avenue

Lake Forest, IL 60045

Email: info@VentureDNA.com

Phone: +(1) 847 604 9400

Fax: +(1) 847 574 0731

© 2025 VentureDNA. All rights reserved. Website developed by Fresh Design Studio
Shopping Basket
Go to mobile version